Instant Analysis: Is Teva Pharmaceutical Industries a Buy on the Dip?

Image source The Motley Fool What happened Teva Pharmaceutical Industries NYSE TEVA 160 took another stock market hit after a U S District Court invalidated four method of use patents protecting a long acting version of Teva s multiple sclerosis drug Copaxone